Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

Valued at a market cap of almost $87.4 billion, Altria Group, Inc. (MO) manufactures and sells smokeable and oral tobacco ...

Bank of America Securities analyst Lisa Lewandowski reiterated a Buy rating on Altria Group (MO – Research Report) yesterday and set a price ...

Between 'vape' products and 'Zyn,' nearly 18% of Idaho high schoolers report regularly using nicotine in some way — many ...

On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.

Robert F. Kennedy Jr., President Donald Trump’s pick for Health and Human Services Secretary, appeared to subtly pop something in his mouth yesterday during his contentious confirmation hearing in the ...

Listen to this article Hasbro board chair and the toymaker’s former interim CEO Richard S. Stoddart will join the Altria Group board of directors Monday, the Henrico County-based, Fortune 500 tobacco ...

Why did Swedish nicotine pouches become a generation's go-to fix for blasting through long work days and longer nights out?

Are non-cigarette tobacco products bad for your heart? KYW medical editor Dr. Brian McDonough looks at a report based on seven decades of research.

Snus, the smokeless tobacco product with Scandinavian origins, has gained popularity among celebrities, particularly athletes and entertainers. With its discreet nature and reduced health risks ...

The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...

Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...